Tricyclic antipsychotics and antidepressants can inhibit α5‐containing GABAA receptors by two distinct mechanisms

Many psychotherapeutic drugs, including clozapine, display polypharmacology and act on GABAA receptors. Patients with schizophrenia show alterations in function, structure and molecular composition of the hippocampus, and a recent study demonstrated aberrant levels of hippocampal α5 subunit‐containing GABAA receptors. The purpose of this study is to investigate the effects of tricyclic compounds on α5 subunit‐containing receptor subtypes.

[1]  Stephen P. H. Alexander,et al.  THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors , 2021, British journal of pharmacology.

[2]  Adam J Pawson,et al.  THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Ion channels , 2021, British journal of pharmacology.

[3]  S. Takao,et al.  The relationship between plasma clozapine concentration and clinical outcome: a cross‐sectional study , 2020, Acta psychiatrica Scandinavica.

[4]  E. Lindahl,et al.  Shared structural mechanisms of general anesthetics and benzodiazepines , 2020, Nature.

[5]  F. Turkheimer,et al.  GABA-A receptor differences in schizophrenia: a positron emission tomography study using [11C]Ro154513 , 2020, Molecular Psychiatry.

[6]  Andrea Cipriani,et al.  Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis , 2019, The Lancet.

[7]  Johannes L. Schönberger,et al.  SciPy 1.0: fundamental algorithms for scientific computing in Python , 2019, Nature Methods.

[8]  M. Mihovilovic,et al.  Defined concatenated α6α1β3γ2 GABAA receptor constructs reveal dual action of pyrazoloquinolinone allosteric modulators. , 2019, Bioorganic & medicinal chemistry.

[9]  Jasenko Zivanov,et al.  GABAA receptor signalling mechanisms revealed by structural pharmacology , 2019, Nature.

[10]  T. V. van Erp,et al.  Hippocampal subregion abnormalities in schizophrenia: A systematic review of structural and physiological imaging studies , 2018, Neuropsychopharmacology reports.

[11]  E. Sigel,et al.  The Benzodiazepine Binding Sites of GABAA Receptors. , 2018, Trends in pharmacological sciences.

[12]  Thierry Langer,et al.  Conformational Sampling of Small Molecules With iCon: Performance Assessment in Comparison With OMEGA , 2018, Front. Chem..

[13]  Steve Alexander,et al.  Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers , 2018, British journal of pharmacology.

[14]  A. Wong,et al.  GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia , 2018, Acta Pharmacologica Sinica.

[15]  S A Small,et al.  Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention , 2018, Molecular Psychiatry.

[16]  E. Sigel,et al.  α subunits in GABAA receptors are dispensable for GABA and diazepam action , 2017, Scientific Reports.

[17]  M. Spedding,et al.  Selective inhibition of extra-synaptic α5-GABAA receptors by S44819, a new therapeutic agent , 2017, Neuropharmacology.

[18]  M. Mihovilovic,et al.  Molecular tools for GABAA receptors: High affinity ligands for β1-containing subtypes , 2017, Scientific Reports.

[19]  M. Mihovilovic,et al.  Molecular tools for GABAA receptors: High affinity ligands for β1-containing subtypes , 2017, Scientific Reports.

[20]  E. Lindahl,et al.  Allosteric binding site in a Cys-loop receptor ligand-binding domain unveiled in the crystal structure of ELIC in complex with chlorpromazine , 2016, Proceedings of the National Academy of Sciences.

[21]  G. Ecker,et al.  Structural Studies of GABAA Receptor Binding Sites: Which Experimental Structure Tells us What? , 2016, Front. Mol. Neurosci..

[22]  R. Hurst,et al.  Therapeutic doses of antidepressants are projected not to inhibit human α4β2 nicotinic acetylcholine receptors , 2013, Neuropharmacology.

[23]  David Taylor,et al.  Comparative Effectiveness of Atypical Antipsychotics in Schizophrenia , 2012, CNS Drugs.

[24]  Maria F. Sassano,et al.  Automated design of ligands to polypharmacological profiles , 2012, Nature.

[25]  M. Oz,et al.  Effects of phenothiazine-class antipsychotics on the function of α7-nicotinic acetylcholine receptors. , 2011, European journal of pharmacology.

[26]  Anthony A Grace,et al.  Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia. , 2011, Trends in pharmacological sciences.

[27]  Gaël Varoquaux,et al.  Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..

[28]  W. Sieghart,et al.  The point mutation gamma 2F77I changes the potency and efficacy of benzodiazepine site ligands in different GABAA receptor subtypes. , 2010, European journal of pharmacology.

[29]  Benjamin A. Ellingson,et al.  Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database , 2010, J. Chem. Inf. Model..

[30]  F. Knoflach,et al.  The discovery and unique pharmacological profile of RO4938581 and RO4882224 as potent and selective GABAA alpha5 inverse agonists for the treatment of cognitive dysfunction. , 2009, Bioorganic & medicinal chemistry letters.

[31]  Edward O. Mann,et al.  Which GABAA Receptor Subunits Are Necessary for Tonic Inhibition in the Hippocampus? , 2008, The Journal of Neuroscience.

[32]  John D. Hunter,et al.  Matplotlib: A 2D Graphics Environment , 2007, Computing in Science & Engineering.

[33]  Thierry Langer,et al.  Efficient overlay of small organic molecules using 3D pharmacophores , 2007, J. Comput. Aided Mol. Des..

[34]  G. Johnston,et al.  The effects of antipsychotic drugs on GABAA receptor binding depend on period of drug treatment and binding site examined , 2007, Schizophrenia Research.

[35]  M. Morales,et al.  Antipsychotic clozapine inhibits the function of α7-nicotinic acetylcholine receptors , 2007, Neuropharmacology.

[36]  P. Hawkins,et al.  Comparison of shape-matching and docking as virtual screening tools. , 2007, Journal of medicinal chemistry.

[37]  G. Dawson,et al.  L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for α5-containing GABAA receptors , 2006, Neuropharmacology.

[38]  T. Bäckström,et al.  GABA‐site antagonism and pentobarbital actions do not depend on the α‐subunit type in the recombinant rat GABAA receptor , 2006, Acta physiologica.

[39]  P. Seeman.  Targeting the dopamine D2 receptor in schizophrenia , 2006, Expert opinion on therapeutic targets.

[40]  C. Gotti,et al.  Brain neuronal nicotinic receptors as new targets for drug discovery. , 2006, Current pharmaceutical design.

[41]  Akira Fukuda,et al.  The effects of neuroleptics on the GABA‐induced Cl− current in rat dorsal root ganglion neurons: differences between some neuroleptics , 2002, British journal of pharmacology.

[42]  E. Saederup,et al.  Additivities of Compounds that Increase the Numbers of High Affinity [3H]Muscimol Binding Sites by Different Amounts Define More than 9 GABAA Receptor Complexes in Rat Forebrain: Implications for Schizophrenia and Clozapine Research , 2000, Neurochemical Research.

[43]  F. Michel,et al.  Clozapine inhibits synaptic transmission at GABAergic synapses established by ventral tegmental area neurones in culture , 2000, Neuropharmacology.

[44]  R. Squires,et al.  Clozapine's Antipsychotic Effects do not Depend on Blockade of 5-HT3 Receptors , 1999, Neurochemical Research.

[45]  E. Cherubini,et al.  Chlorpromazine Inhibits Miniature GABAergic Currents by Reducing the Binding and by Increasing the Unbinding Rate of GABAAReceptors , 1999, The Journal of Neuroscience.

[46]  R. Squires,et al.  Clozapine and Several Other Antipsychotic/Antidepressant Drugs Preferentially Block the Same ‘Core’ Fraction of GABAA Receptors , 1998, Neurochemical Research.

[47]  G. Sperk,et al.  GABAA receptor subunits in the rat hippocampus I: Immunocytochemical distribution of 13 subunits , 1997, Neuroscience.

[48]  R. Squires,et al.  Clozapine and Some Other Antipsychotic Drugs May Preferentially Block the Same Subset of GABAA Receptors , 1997, Neurochemical Research.

[49]  A. Delini-Stula,et al.  Antipsychotic effects of bretazenil, a partial benzodiazepine agonist in acute schizophrenia--a study group report. , 1996, Journal of psychiatric research.

[50]  R. Squires,et al.  Mono N-Aryl ethylenediamine and piperazine derivatives are GABAA receptor blockers: Implications for psychiatry , 1993, Neurochemical Research.

[51]  R. Squires,et al.  A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: More support for a continuum hypothesis of “functional” psychosis , 1991, Neurochemical Research.

[52]  M. Santi,et al.  Neurosteroids act on recombinant human GABAA receptors , 1990, Neuron.

[53]  R. D. Schwartz,et al.  Inhibition of the GABA receptor-gated chloride ion channel in brain by noncompetitive inhibitors of the nicotinic receptor-gated cation channel. , 1988, The Journal of pharmacology and experimental therapeutics.

[54]  R. Squires,et al.  Antidepressants and metabolites that block GABAA receptors coupled to 35S-t-butylbicyclophosphorothionate binding sites in rat brain , 1988, Brain Research.

[55]  R. Squires,et al.  GABAA receptor blockers reverse the inhibitory effect of GABA on brain-specific [35S]TBPS binding , 1987, Brain Research.

[56]  P. Seeman.  Brain dopamine receptors. , 1980, Pharmacological reviews.

[57]  Thierry Langer,et al.  LigandScout: 3-D Pharmacophores Derived from Protein-Bound Ligands and Their Use as Virtual Screening Filters , 2005, J. Chem. Inf. Model..

[58]  E. Seu,et al.  Synthesis and pharmacological evaluation of 1-[(1,2-diphenyl-1H-4-imidazolyl)methyl]-4-phenylpiperazines with clozapine-like mixed activities at dopamine D(2), serotonin, and GABA(A) receptors. , 2002, Journal of medicinal chemistry.

[59]  K. Wohlfarth,et al.  Enhanced neurosteroid potentiation of ternary GABA(A) receptors containing the delta subunit. , 2002, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[60]  J Tauscher,et al.  Significant dissociation of brain and plasma kinetics with antipsychotics , 2002, Molecular Psychiatry.

[61]  G. Sperk,et al.  GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. , 2000, Neuroscience.

[62]  E. Korpi,et al.  Subtype specificity of gamma-aminobutyric acid type A receptor antagonism by clozapine. , 1995, Naunyn-Schmiedeberg's archives of pharmacology.

[63]  Sidney M. Hecht,et al.  Structural Studies of , 1979 .